Qsymia contains two active ingredients that leave your body at very different rates. The phentermine component has a half-life of about 20 hours, meaning it clears your system in roughly 4 to 5 days after your last dose. The topiramate component, formulated as extended-release in Qsymia, has a much longer half-life of about 65 hours, so it takes approximately 13 to 14 days to fully clear. Topiramate is the reason Qsymia lingers in your body well after you stop taking it.
How the Two Components Clear Separately
A drug is generally considered eliminated after about five half-lives, when roughly 97% of it has been processed out. For the phentermine in Qsymia, five half-lives of 20 hours each adds up to about 100 hours, or just over 4 days. You’ll likely notice its stimulant-like effects fading within the first day or two, but trace amounts remain a bit longer.
Topiramate takes considerably longer. With a half-life of about 65 hours in Qsymia’s extended-release form, five half-lives works out to roughly 325 hours, or about 13.5 days. This component is not heavily broken down by your liver. Instead, about 70% of it passes through your kidneys unchanged and exits in your urine. That means your kidney function plays an outsized role in how quickly topiramate actually leaves.
Factors That Slow Clearance
Because both ingredients are cleared primarily through the kidneys, reduced kidney function can extend these timelines significantly. People with moderate or severe kidney impairment build up higher concentrations of both phentermine and topiramate in their blood compared to people with normal kidney function. For this reason, people with kidney problems are typically kept on lower doses, and clearance after stopping can take noticeably longer than the estimates above.
Liver function also affects how long phentermine sticks around. People with moderate liver impairment show higher phentermine exposure than healthy individuals. Topiramate is less affected by liver health since most of it bypasses liver metabolism entirely, but the combination of reduced kidney and liver function could meaningfully extend total clearance time beyond two weeks.
Other individual factors matter too. Body composition, age, hydration, and urine pH can all influence how efficiently your kidneys filter out these compounds. There’s no single number that applies to everyone, but for most people with normal organ function, the 13 to 14 day window for full clearance is a reasonable estimate.
Why You Can’t Stop Qsymia Abruptly
Even though Qsymia leaves your system gradually on its own, you should not stop taking it all at once, especially at the highest dose. The topiramate component can cause seizures if withdrawn suddenly, even in people who have never had a seizure before. The FDA labeling is explicit about this: abrupt discontinuation of topiramate has been associated with seizures in individuals without any history of epilepsy.
The recommended approach for the highest dose (15 mg/92 mg) is to take it every other day for at least one week before stopping completely. This gives your brain time to adjust to declining topiramate levels rather than experiencing a sharp drop. If you’re on a lower dose, the seizure risk is smaller, but a gradual taper is still the safest path. If a medical situation requires you to stop immediately, monitoring should be in place.
Drug Testing Considerations
Phentermine is structurally similar to amphetamine, and it can trigger a positive result on standard urine drug screens for amphetamines. This is a well-known issue with phentermine-based medications. If you’re subject to workplace or other drug testing, the phentermine component could show up for several days after your last dose. A confirmatory test (which identifies the specific compound rather than just the drug class) would distinguish phentermine from actual amphetamines, but you may need to disclose your prescription ahead of time to avoid complications.
Topiramate is not typically included in standard drug panels and is unlikely to cause any false positives. It is detectable through specific blood or urine tests if a clinician is looking for it, and given its longer half-life, it would remain detectable for roughly two weeks.
What to Expect as Qsymia Leaves Your Body
As phentermine clears first, the appetite-suppressing and energy-boosting effects tend to fade within the first few days. Some people notice increased hunger returning relatively quickly. The topiramate component, which also contributes to appetite reduction and affects how your body processes certain foods, tapers off more slowly over the following week or so.
Some people experience rebound effects as both drugs leave their system, including stronger appetite, mild fatigue, or mood changes. These are generally temporary and reflect your body readjusting to functioning without the medication rather than a sign of a lasting problem. The gradual taper helps minimize these effects by giving your nervous system a smoother transition.